Picture of Roopa Industries logo

530991 Roopa Industries Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+2%
3m-3.74%
6m+5.36%
1yr-7.3%
Volume Change (%)
10d/3m-55.09%
Price vs... (%)
52w High-16.6%
50d MA+4.94%
200d MA+19.84%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.62%
Return on Equity9.19%
Operating Margin4.28%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m301.5276.47286.11512.05761.72n/an/a31.27%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+13.82-39.41+92.51+41.72+32.95n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Roopa Industries EPS forecast chart

Profile Summary

Roopa Industries Limited is engaged in active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is engaged in the manufacturing of bulk drugs/drug intermediates. The Company’s products include N,N- dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is a product used by the manufacturers of the Cephalosporin group of Antibiotics and Statins. It is used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to Agriculture. Glucosamine is a sheet anchor product that is a nutraceutical / nutritional supplement. Bromine And Its Derivatives offers agrochemicals, dyes, various organic and inorganic for medical & veterinary products, gasoline applications, water purification compounds, disinfectants, insecticides, and pesticides.

Directors

    Last Annual
    March 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    June 17th, 1985
    Public Since
    May 24th, 1995
    No. of Employees
    35
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    in flag iconBombay Stock Exchange
    Shares in Issue
    7,865,520

    530991 Share Price Performance

    Upcoming Events for 530991

    Q4 2024 Roopa Industries Ltd Earnings Release

    Q1 2025 Roopa Industries Ltd Earnings Release

    Similar to 530991

    Picture of Achyut Healthcare logo

    Achyut Healthcare

    in flag iconBombay Stock Exchange

    Picture of Adline Chem Lab logo

    Adline Chem Lab

    in flag iconBombay Stock Exchange

    Picture of MPS Pharmaa logo

    MPS Pharmaa

    in flag iconBombay Stock Exchange

    Picture of Albert David logo

    Albert David

    in flag iconBombay Stock Exchange

    Picture of Ambalal Sarabhai Enterprises logo

    Ambalal Sarabhai Enterprises

    in flag iconBombay Stock Exchange

    FAQ